Resultats de la cerca - Stephan Duparc
- Mostrar 1 - 20 resultats de 45
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration per Carrie A. Morris, Stephan Duparc, Isabelle Borghini-Fuhrer, Donald Jung, Chang-Sik Shin, Lawrence Fleckenstein
Publicat 2011Revisão -
6
-
7
-
8
Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women... per Joshua Kimani, Kamija S. Phiri, Steve Kamiza, Stephan Duparc, Ayman Ayoub, Ricardo Rojo, Jeffery Robbins, Russell Orrico, Pol Vandenbroucke
Publicat 2016Artigo -
9
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials per Stephan Duparc, Isabelle Borghini-Fuhrer, Carl J Craft, Sarah Arbe‐Barnes, Robert M. Miller, Chang-Sik Shin, Lawrence Fleckenstein
Publicat 2013Artigo -
10
-
11
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase... per Aung Pyae Phyo, Podjanee Jittamala, François Nosten, Sasithon Pukrittayakamee, Mallika Imwong, Nicholas J. White, Stephan Duparc, Fiona Macintyre, Mark Baker, Jörg J. Möhrle
Publicat 2015Artigo -
12
New developments in anti-malarial target candidate and product profiles per Jeremy N. Burrows, Stephan Duparc, Winston E. Gutteridge, Rob Hooft van Huijsduijnen, Wiweka Kaszubska, Fiona Macintyre, Sébastien Mazzuri, Jörg J. Möhrle, Timothy N. C. Wells
Publicat 2017Revisão -
13
Estimation of the Antirelapse Efficacy of Tafenoquine, Using<i>Plasmodium vivax</i>Genotyping per Hans‐Peter Beck, Rahel Wampfler, Nick Carter, Gavin Koh, Lyda Osório, Ronnatrai Rueangweerayut, Srivcha Krudsood, Marcus Lacerda, Alejandro Llanos‐Cuentas, Stephan Duparc, Justin P. Rubio, Justin A. Green
Publicat 2015Artigo -
14
First‐in‐man safety and pharmacokinetics of synthetic ozonide <scp>OZ439</scp> demonstrates an improved exposure profile relative to other peroxide antimalarials per Joerg J. Moehrle, Stephan Duparc, Christoph Siethoff, Paul L. M. van Giersbergen, J. Carl Craft, Sarah Arbe‐Barnes, Susan A. Charman, María J. Gutiérrez, Sergio Wittlin, Jonathan L. Vennerstrom
Publicat 2012Artigo -
15
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial per Pamela L. St. Jean, Zhengyu Xue, Nick Carter, Gavin Koh, Stephan Duparc, Maxine Taylor, Claire Beaumont, Alejandro Llanos‐Cuentas, Ronnatrai Rueangweerayut, Srivicha Krudsood, Justin A. Green, Justin P. Rubio
Publicat 2016Artigo -
16
Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel <i>Plasmodium</i> Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers per Phumla Sinxadi, Cristina Donini, Hilary Johnstone, Grant Langdon, Lubbe Wiesner, Elizabeth Allen, Stephan Duparc, Stephan Chalon, James McCarthy, Ulrike Lorch, Kelly Chibale, Jörg J. Möhrle, Karen I. Barnes
Publicat 2020Artigo -
17
Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial per Poravuth Yi, Duong Socheat, Ronnatrai Rueangweerayut, Chirapong Uthaisin, Aung Pyae Phyo, Neena Valecha, Bappanad H. K. Rao, Emiliana Tjitra, Asep Purnama, Isabelle Borghini-Fuhrer, Stephan Duparc, Changsik Shin, Lawrence Fleckenstein
Publicat 2011Artigo -
18
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria per Fiona Macintyre, Hanu Ramachandruni, Jeremy N. Burrows, René Holm, Anna Thomas, Jörg J. Möhrle, Stephan Duparc, Rob Hooft van Huijsduijnen, Brian Greenwood, Winston E. Gutteridge, Timothy N. C. Wells, Wiweka Kaszubska
Publicat 2018Revisão -
19
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects per Ann K. Miller, Emma Harrell, Ye Li, Sharon Baptiste‐Brown, Jőrg‐Peter Kleim, Colin Ohrt, Stephan Duparc, Jörg J. Möhrle, Alison Webster, Sandra S. Stinnett, Arlene R. Hughes, Sandy Griffith, Andrew P. Beelen
Publicat 2013Artigo -
20
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia per Rithea Leang, Sara E. Canavati, Nimol Khim, Lasse S Vestergaard, Isabelle Borghini‐Fuhrer, Saorin Kim, Mey Bouth Denis, Pisal Heng, Bunkea Tol, Rekol Huy, Stephan Duparc, Arjen M. Dondorp, Didier Ménard, Pascal Ringwald
Publicat 2016Artigo
Eines de cerca:
Matèries relacionades
Medicine
Immunology
Malaria
Plasmodium falciparum
Internal medicine
Pharmacology
Artemisinin
Plasmodium vivax
Chloroquine
Primaquine
Artesunate
Biology
Environmental health
Adverse effect
Clinical trial
Tolerability
Pharmacokinetics
Population
Randomized controlled trial
Virology
Artemether
Artemether/lumefantrine
Biochemistry
Confidence interval
Intensive care medicine
Mefloquine
Pathology
Gastroenterology
Piperaquine
Vivax malaria